Director, Marketing Sciences

Gilead Sciences•Foster City, CA

9d•$226,185 - $292,710

About The Position

Gilead is seeking a Director, Marketing Sciences for GDSI Oncology Integrated Insights, supporting gynecologic cancers, small cell lung cancer, and selected oncology pipeline opportunities. The role integrates forecasting, analytics, primary market research, secondary data, and competitive evidence to inform commercial strategy, clinical and development decisions, launch readiness, lifecycle planning, and investment choices. This is a hands-on role requiring ownership of both the strategic narrative and technical analysis. The Director frames decisions and uncertainties, selects appropriate methods, tests assumptions, builds or modifies analyses as needed, and translates evidence into concise recommendations for senior cross-functional stakeholders. The role also represents GDSI in commercialization, indication, and asset forums and supports global and local teams with consistent evidence and forecast logic. The Director owns long-term forecasts and scenario planning, leads qualitative and quantitative research, evaluates secondary data and competitive evidence, and supports indication and pipeline assessments. The position includes model governance, quality reviews, vendor management, process improvement, and coaching colleagues and contractors. People-leader responsibilities include creating inclusion, developing talent, and empowering teams.

Requirements

Bachelor's degree and 12 years of relevant experience, or a master's degree and 10 years of relevant experience, or a PhD and 8 years of relevant experience.
Hands-on expertise in strategic forecasting, commercial analytics, and qualitative and quantitative market research in biopharmaceuticals or healthcare.
Ability to independently understand, audit, modify, and build patient-based and revenue forecast models in Excel.
Depth in oncology market dynamics, clinical evidence interpretation, treatment sequencing, launch planning, and lifecycle strategy.
Ability to synthesize varied and imperfect evidence, identify important assumptions, test alternative explanations, and make clear recommendations under uncertainty.
Experience with pharmaceutical data sources such as IQVIA/IMS, epidemiology, claims or patient-level data, treatment-pattern studies, and chart audits.
Strong cross-functional leadership and ability to influence without authority, resolve disagreement, and align commercial, clinical, medical, finance, market access, corporate development, and affiliate stakeholders.
Executive communication skills, including explaining technical model logic and uncertainty in concise, decision-relevant language.
Strong project and vendor management skills, including prioritization under tight timelines and changing business needs.
Advanced proficiency in Microsoft Excel and PowerPoint.

Nice To Haves

Advanced degree in business, economics, statistics, data science, life sciences, medicine, or another relevant quantitative discipline.
Significant pharmaceutical or biotechnology experience, including substantial direct work in forecasting, analytics, and market research.
Experience supporting global launches, pipeline assets, indication expansion, and senior governance decisions.
Oncology experience across commercial and development-stage questions.
Experience in gynecologic cancers, lung cancer, antibody-drug conjugates, or oncology pipeline strategy.
Experience with enterprise forecasting platforms; Forecast Horizon experience is preferred.
Experience leading matrix teams and developing colleagues.
Direct people-management experience is beneficial but not required unless designated in the final organizational design.

Responsibilities

Partner with Global Strategic Marketing and cross-functional teams as an objective insights leader for gynecologic cancers, small cell lung cancer, and selected pipeline assets.
Frame business questions as decisions, hypotheses, evidence needs, and analytical workplans with clear ownership, timing, and decision criteria.
Integrate forecasting, analytics, market research, competitive intelligence, epidemiology, clinical evidence, and affiliate perspectives into actionable market assessments.
Present findings and recommendations to senior stakeholders, distinguish evidence from judgment, communicate uncertainty, and drive alignment on decisions and next steps.
Represent GDSI on commercialization, indication, and asset forums and prioritize insights work according to strategic and financial consequences.
Own long-term strategic forecasts for GYN, SCLC, and assigned pipeline assets, incorporating epidemiology, patient segmentation, treatment, uptake, access, pricing, launch timing, and competitive evolution.
Design base, upside, downside, and event-driven scenarios and quantify direct and second-order effects across indications, products, and shared patient pools.
Navigate, audit, modify, extend, troubleshoot, or build Forecast Horizon and Excel-based models to answer business questions.
Use analytical methods such as waterfalls, variance bridges, sensitivities, tornado analyses, scenario comparisons, and input comparisons to validate drivers and expose uncertainty.
Maintain transparent assumption inventories, source documentation, change logs, model controls, and quality checks.
Set research and analytics priorities based on business decisions, knowledge gaps, and the value of additional evidence.
Lead qualitative and quantitative primary research among physician, patient, and payer audiences, including treatment-flow, segmentation, drivers-and-barriers, positioning, message testing, product assessment, demand estimation, and launch-readiness research.
Analyze and triangulate secondary data, evaluating population definitions, business rules, sample limitations, and clinical and commercial plausibility.
Translate product profiles, clinical outcomes, safety, tolerability, administration, access, evidence maturity, and competitive timing into adoption and share assumptions.
Partner with regional and local Insights teams to incorporate market-specific evidence while maintaining globally consistent definitions, assumptions, and forecast logic.
Support GYN studies and strategy through forecasting, market development insights, launch-readiness research, competitive assessment, and evaluation of follow-on opportunities.
Support SCLC studies and indication planning through treatment-flow and sequencing analysis, research, launch scenarios, forecast updates, and competition assessments.
Lead opportunity assessments, target-product-profile interpretation, demand estimation, scenario valuation, and evidence planning for selected oncology pipeline assets and external opportunities.
Make patient-flow logic and treatment-history assumptions explicit, particularly where prior ADC or class exposure affects addressability, sequencing, adoption, or duration.
Review models and analyses for structural, calculation, and reasonableness issues, including double counting, inconsistent populations, hidden constraints, manual overrides, broken links, circularity, and unsupported assumptions.
Challenge disconnects among product profiles, evidence, demand research, competitive assessments, analogs, forecast assumptions, and revenue outcomes.
Manage external research and analytics partners and ensure methods and deliverables are fit for purpose and withstand technical and business scrutiny.
Coach colleagues and contractors on forecast logic, model hygiene, research design, and executive communication.
Improve the consistency, efficiency, rigor, and credibility of oncology portfolio processes, templates, and decision support.
As a people leader, create inclusion, develop talent, align teams to organizational objectives, and empower employees by helping remove barriers.